Reuters: Teva to buy Barr for $7.46 billion, boost generic lead

[chris]

Teva to buy Barr for $7.46 billion, boost generic lead
      

NEW YORK (Reuters) - Teva Pharmaceutical Industries   said on Friday it would buy rival generic drugmaker Barr Pharmaceuticals Inc  for $7.46 billion to expand its leadership in the U.S. market and fortify its presence in Europe.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login